Table 4.
Concentrations of cytokines in the different study groups
| Cytokine | Controls (pg/ml) | Cases (pg/ml) | Case 1 (pg/ml) | Case 2 (pg/ml) | P1 | P2 | P3 | P4 |
|---|---|---|---|---|---|---|---|---|
| CXCL5 | 605.17 | 6107.71 | 4392.90 | 9870.78 | <0.01** | <0.01** | <0.01** | 0.20 |
| CXCL6 | 8205.34 | 9026.83 | 9021.59 | 9038.19 | 0.855 | 0.951 | 0.759 | 0.855 |
| CXCL8 | 505.63 | 2419.65 | 1919.96 | 3486.57 | <0.01** | <0.01** | <0.01** | 0.501 |
| IL16 | 54.33 | 345.66 | 186.09 | 686.37 | <0.01** | <0.01** | <0.01** | <0.05* |
| CCL8 | 65.06 | 255.24 | 319.75 | 113.68 | <0.05* | <0.05* | <0.05* | 0.546 |
| CCL7 | 77.79 | 100.54 | 88.14 | 127.03 | 0.914 | 0.932 | 0.921 | 0.955 |
| CCL22 | 669.89 | 1161.39 | 985.81 | 1536.28 | 0.088 | 0.128 | 0.206 | 0.815 |
| CCL20 | 723.49 | 2605.39 | 2358.24 | 3133.09 | <0.01** | <0.01** | <0.01** | 0.600 |
| CCL19 | 40.51 | 42.20 | 40.39 | 46.05 | 0.996 | 0.986 | 0.984 | 0.993 |
| CXCL16 | 765.74 | 721.01 | 708.89 | 746.89 | 0.063 | <0.05* | 0.589 | 0.293 |
| IL1B | 1.63 | 30.88 | 25.15 | 44.03 | <0.01** | <0.01** | <0.01** | 0.256 |
| IL6 | 16.90 | 103.44 | 66.22 | 188.82 | <0.01** | <0.01** | <0.01** | 0.062 |
| IL7 | 863.28 | 690.68 | 728.74 | 603.38 | <0.01** | <0.05* | <0.01** | 0.082 |
| IL10 | 2.81 | 14.52 | 11.42 | 21.65 | <0.01** | <0.01** | <0.01** | 0.580 |
| CSF3 | 30.75 | 198.98 | 202.77 | 190.27 | <0.01** | <0.01** | <0.01** | 0.957 |
| CCL3 | 2.06 | 36.02 | 21.93 | 68.35 | <0.01** | <0.01** | <0.01** | 0.339 |
| CCL4 | 95.79 | 525.47 | 393.96 | 827.17 | <0.01** | <0.01** | <0.01** | 0.425 |
| TNF-α | 5.41 | 24.57 | 20.59 | 33.72 | <0.01** | <0.01** | <0.01** | 0.882 |
Controls, semen samples with low ROS. Case 1, normal semen parameters with high ROS. Case 2, abnormal semen parameters with high ROS. Cases: Case 1 + Case 2
P1 control vs. cases, P2 control vs. cases1, P3 control vs. case 2, P4 case 1 vs. case 2
*P < 0.05; **P < 0.01